Bone development in offspring of pregnant rats treated with carbamazepine: Evaluation by three different methods

This study was carried out to determine the effect of intrauterine carbamazepine (CBZ) exposure on fetal bone development during pregnancy.

[1]  R. Yan,et al.  Carbamazepine Induces Platelet Apoptosis and Thrombocytopenia Through Protein Kinase A , 2021, Frontiers in Pharmacology.

[2]  Y. Kaplan,et al.  Use of phenytoin, phenobarbital carbamazepine, levetiracetam lamotrigine and valproate in pregnancy and breastfeeding: risk of major malformations, dose-dependency, monotherapy vs polytherapy, pharmacokinetics and clinical implications. , 2021, Current neuropharmacology.

[3]  Zhoushan Tao,et al.  Effect of alendronate on the femoral metaphyseal defect under carbamazepine in ovariectomized rats , 2021, Journal of Orthopaedic Surgery and Research.

[4]  O. Osuntokun,et al.  Graded doses of grape seed methanol extract attenuated hepato-toxicity following chronic carbamazepine treatment in male Wistar rats , 2020, Toxicology reports.

[5]  Li Cui,et al.  Effect of carbamazepine on the bone health of people with epilepsy: a systematic review and meta-analysis , 2020, The Journal of international medical research.

[6]  R. Huntsman,et al.  Cannabis for Pediatric Epilepsy. , 2020, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[7]  R. Reynoso-Robles,et al.  Prenatal exposure to oxcarbazepine increases hippocampal apoptosis in rat offspring , 2019, Journal of Chemical Neuroanatomy.

[8]  R. Colebunders,et al.  Women with epilepsy in sub–Saharan Africa: A review of the reproductive health challenges and perspectives for management , 2019, Seizure.

[9]  E. Unur,et al.  Impact of prenatal exposure to bisphenol A on pregnant rats: Fetal bone development and immunohistochemistry implications , 2019, Toxicology and industrial health.

[10]  F. Benninger,et al.  Antiepileptic drug treatment during pregnancy and delivery in women with epilepsy—A retrospective single center study , 2019, Epilepsy Research.

[11]  N. Mahmutbegović,et al.  Effect of Long-term Carbamazepine Therapy on Bone Health , 2018, Medical archives.

[12]  D. Vohora,et al.  The anti-epileptic drugs valproate, carbamazepine and levetiracetam cause bone loss and modulate Wnt inhibitors in normal and ovariectomised rats. , 2018, Bone.

[13]  S. Kochen,et al.  Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry , 2018, The Lancet Neurology.

[14]  I. Scheffer,et al.  The management of epilepsy in children and adults , 2018, The Medical journal of Australia.

[15]  M. Namavar,et al.  The influence of interferon-γ on cardiac and renal histopathological changes induced by carbamazepine. , 2018, Bratislavske lekarske listy.

[16]  S. Ganesh,et al.  A Case of Carbamazepine-induced Severe Cholestatic Hepatitis: Case Report and Review of Literature , 2017, Indian journal of psychological medicine.

[17]  T. Akunne,et al.  Toxicological Profile of Carbamazepine and Levetiracetam on Some Biochemical and Haematological Parameters in Rats , 2017 .

[18]  A. Tricco,et al.  Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes , 2017, BMC Medicine.

[19]  R. Ahmed,et al.  Maternal carbamazepine alters fetal neuroendocrine-cytokines axis. , 2017, Toxicology.

[20]  Sanjeev V Thomas,et al.  Teratogenic Effects of Carbamazepine in Mice , 2017, Annals of Indian Academy of Neurology.

[21]  M. Batum,et al.  How Should Antiepileptic Drugs Be Selected During Pregnancy , 2017 .

[22]  Qingmei Nie,et al.  Neurological teratogenic effects of antiepileptic drugs during pregnancy , 2016, Experimental and therapeutic medicine.

[23]  Michael A. Thomas,et al.  Maternal exposure to carbamazepine at environmental concentrations can cross intestinal and placental barriers. , 2016, Biochemical and biophysical research communications.

[24]  Said Said Elshama,et al.  Teratogenic effect of Carbamazepine use during pregnancy in the mice. , 2015, Pakistan journal of pharmaceutical sciences.

[25]  M. Silvestrini,et al.  Seizure course during pregnancy in catamenial epilepsy , 2014, Neurology.

[26]  F. Sadeghi.  TWO SEPARATED PROTOCOLS WITH THE MOST IMPORTANT COMMENTS FOR SKELETAL STAINING IN EMBRYONIC AND ADULTHOOD PERIOD IN LABORATORY ANIMALS , 2014 .

[27]  N. Delanty,et al.  Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[28]  J. Asconapé.  Use of antiepileptic drugs in hepatic and renal disease. , 2014, Handbook of clinical neurology.

[29]  H. Scharfman,et al.  Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research , 2013, Epilepsy & Behavior.

[30]  D. Şahin,et al.  Effects of carbamazepine on serum parathormone, 25- hydroxyvitamin D, bone specific alkaline phosphatase, C-telopeptide, and osteocalcin levels in healthy rats. , 2012, Bosnian journal of basic medical sciences.

[31]  Jinsook Kim,et al.  Pattern of antiepileptic drug–induced cell death in limbic regions of the neonatal rat brain , 2011, Epilepsia.

[32]  T. Tomson,et al.  The pharmacological treatment of epilepsy in adults , 2011, The Lancet Neurology.

[33]  A. Shiravi,et al.  Teratogenic effects of carbamazepine on embryonic eye development in pregnant mice , 2010, Cutaneous and ocular toxicology.

[34]  J. Litvoc,et al.  Comparison of carbamazepine and lithium in treatment of bipolar disorder: A systematic review of randomized controlled trials , 2009, Human psychopharmacology.

[35]  Y. Kitamura,et al.  Chronic coadministration of carbamazepine together with imipramine produces antidepressant-like effects in an ACTH-induced animal model of treatment–resistant depression: Involvement of 5-HT2A receptors? , 2008, Pharmacology Biochemistry and Behavior.

[36]  L. Gjerstad,et al.  How can antiepileptic drugs affect bone mass, structure and metabolism? Lessons from animal studies , 2008, Seizure.

[37]  G. Brabant,et al.  Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy , 2008, European Journal of Pediatrics.

[38]  N. Namboodiri,et al.  Cardiac Malformations Are Increased in Infants of Mothers with Epilepsy , 2008, Pediatric Cardiology.

[39]  R. Sheth,et al.  Bone consequences of epilepsy and antiepileptic medications. , 2007, Seminars in pediatric neurology.

[40]  D. Thurman,et al.  How common are the “common” neurologic disorders? , 2007, Neurology.

[41]  C. Bearer.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2007 .

[42]  S. Kumandas,et al.  Effect of carbamezapine and valproic acid on bone mineral density, IGF-I and IGFBP-3. , 2006, Journal of pediatric endocrinology & metabolism : JPEM.

[43]  B. Irwin,et al.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[44]  D. Wyszynski,et al.  North American Antiepileptic Drug Pregnancy Registry , 2004, Epilepsia.

[45]  B. Vazquez,et al.  Bone disease associated with antiepileptic drugs. , 2004, Cleveland Clinic journal of medicine.

[46]  B. Källén,et al.  Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation‐wide, population‐based register study , 2004, Acta paediatrica.

[47]  V. Hiilesmaa,et al.  Normal intelligence in children with prenatal exposure to carbamazepine , 2004, Neurology.

[48]  G. Fuleihan,et al.  Effect of antiepileptic drugs on bone density in ambulatory patients , 2002, Neurology.

[49]  E. Menegola,et al.  Atlas of rat fetal skeleton double stained for bone and cartilage. , 2001, Teratology.

[50]  F. Chiarelli,et al.  Increased bone turnover in epileptic patients treated with carbamazepine , 2000, Annals of neurology.

[51]  K. Korach,et al.  Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring. , 1996, Endocrinology.

[52]  W. Hauser.  The Prevalence and Incidence of Convulsive Disorders in Children , 1994, Epilepsia.

[53]  M. England,et al.  The Developing Human: Clinically Oriented Embryology , 1973 .

[54]  N. Callaghan,et al.  A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. , 1986, The Quarterly journal of medicine.

[55]  M. Stromberg,et al.  Anatomy and embryology of the laboratory rat , 1986 .

[56]  I. Kihlström,et al.  Calcification of the rabbit fetal skeleton. , 1986, Growth.

[57]  W. Sack,et al.  Prenatal Development of Domestic and Laboratory Mammals: Growth Curves, External Features and Selected References , 1973, Zentralblatt fur Veterinarmedizin. Reihe C: Anatomie, Histologie, Embryologie.

[58]  R. Fanelli,et al.  Mass spectrometric characterization of carbamazepine-10,11-epoxide, a carbamazepine metabolite isolated from human urine. , 1972, Journal of pharmaceutical sciences.

[59]  A. Richens,et al.  Calcium metabolism in patients with epilepsy. , 1970, British medical journal.